Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Cogent Biosciences, Inc.
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Willing to provide informed consent for participation in the study
Received at least 1 dose of an ACTR T cell product in an investigational or other treatment setting, such as compassionate use, named patient IND, expanded access program, or equivalent settings
Has completed study assessments and follow-up visits in the prior study or other investigational setting to the extent willing and able to do so
Able to comply with study requirements
You may not be if
None
Clareo Health | Long-Term Follow-Up Study of Subjects Treated With ACTR T Cell Product
